Companies and People News for January 2014

Companies and People News Archive

Royal Society of Chemistry and Cogent combine forces on future talent recruitment incentives Royal Society of Chemistry and Cogent combine forces on future talent recruitment incentives

The Royal Society of Chemistry and Cogent have signed a Memorandum of Agreement to work in partnership to help small and medium-sized companies in the chemicals industry to recruit the best talent.

UCB launches online challenge to find next generation of breakthrough medicines UCB launches online challenge to find next generation of breakthrough medicines

UCB has announced the global launch of its ‘Innovation Challenge’, reinforcing its role as a pioneering science-skills leader. This new online challenge seeks to find rare phenotypes - for example, people who are somehow protected from disease or possess exceptional tissue regeneration. By better understanding the molecular basis of a rare phenotype, UCB scientists hope to be able to develop new medicines for the treatment of severe diseases such as rheumatoid arthritis or multiple sclerosis.

NanoKTN helps The University of Manchester and European Thermodynamics Ltd set up UK Thermoelectric Network (TEMPEST) NanoKTN helps The University of Manchester and European Thermodynamics Ltd set up UK Thermoelectric Network (TEMPEST)

TEMPEST (ThermoElectric Materials, Physics, Electronics and SysTems) Network to launch on 26th February 2014 in ManchesterThe Nanotechnology Knowledge Transfer Network (NanoKTN – www.nanoktn.com), one of the UK’s primary knowledge-based networks for Micro and Nanotechnologies, is pleased to announce its support for the first UK Thermoelectric Network – TEMPEST, funded through the Engineering & Physical Sciences Research Council (EPSRC).

Plans revealed for new world-class science park in East Midlands Plans revealed for new world-class science park in East Midlands

Loughborough is the location for a 70-acre world-class science and technology park as development of a former pharmaceutical research and development site gets underway.

Astellas To Form Strategic Partnership With Clearpath To Build Vaccine Portfolio Astellas To Form Strategic Partnership With Clearpath To Build Vaccine Portfolio

In-license Vaccine Technology for Respiratory Syncytial Virus (RSV) from Mymetics

Growing Demand For Science Manufacturing At Hi-Tech Park, Minister Told Growing Demand For Science Manufacturing At Hi-Tech Park, Minister Told

A government minister has been told that rising demand for life sciences manufacturing at one of Britain’s fastest-growing hi-tech business parks is set to herald a new building programme.